Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Tradeweb Markets
TW
$21.4B
| $973K | ﹤0.01% |
9,345
+1
| +0% | +$101 |
|
|
SIX
1652
DELISTED
Six Flags Entertainment Corp.
SIX
| $972K | ﹤0.01% |
36,927
-52
| -0.1% | -$1.3K |
|
1653
nCino
NCNO
$2.02B
| $970K | ﹤0.01% |
25,950
+1
| +0% | +$31 |
|
|
SWTX
1654
DELISTED
SpringWorks Therapeutics
SWTX
| $968K | ﹤0.01% |
19,671
-19,902
| -50% | -$920K |
|
|
NUVL
1655
DELISTED
Nuvalent
NUVL
| $965K | ﹤0.01% |
12,850
+7
| +0.1% | +$557 |
|
1656
Cheesecake Factory
CAKE
$5.04B
| $965K | ﹤0.01% |
26,706
+1
| +0% | +$35 |
|
|
OPLN
1657
Openlane
OPLN
$4.21B
| $965K | ﹤0.01% |
55,807
+1
| +0% | +$15 |
|
1658
FMC
FMC
$1.34B
| $965K | ﹤0.01% |
15,145
+1
| +0% | +$58 |
|
1659
Tennant Co
TNC
$1.43B
| $963K | ﹤0.01% |
7,919
| – | – |
|
1660
First Merchants
FRME
$2.68B
| $962K | ﹤0.01% |
27,589
| – | – |
|
1661
Chewy
CHWY
$9.25B
| $959K | ﹤0.01% |
60,314
+8
| +0% | +$144 |
|
1662
Expro Ltd
XPRO
$1.79B
| $957K | ﹤0.01% |
47,936
+18
| +0% | +$323 |
|
|
ECHO
1663
EchoStar
ECHO
$24.4B
| $956K | ﹤0.01% |
67,116
+46,896
| +232% | +$654K |
|
1664
Park National Corp
PRK
$3.76B
| $952K | ﹤0.01% |
7,032
+1
| +0% | +$130 |
|
1665
Bio-Rad Laboratories Class A
BIO
$8.71B
| $952K | ﹤0.01% |
2,756
+3
| +0.1% | +$987 |
|
1666
Dutch Bros
BROS
$9.03B
| $952K | ﹤0.01% |
28,864
+92
| +0.3% | +$2.71K |
|
1667
Rivian
RIVN
$22B
| $949K | ﹤0.01% |
86,622
-10,090,173
| -99% | -$145M |
|
1668
NatWest
NWG
$75.3B
| $949K | ﹤0.01% |
139,503
+625
| +0.5% | +$3.71K |
|
1669
Banc of California
BANC
$3.03B
| $946K | ﹤0.01% |
62,172
+51
| +0.1% | +$709 |
|
1670
NovoCure
NVCR
$1.73B
| $943K | ﹤0.01% |
60,400
+2
| +0% | +$29 |
|
1671
Enerpac Tool Group
EPAC
$1.83B
| $939K | ﹤0.01% |
26,335
+5
| +0% | +$161 |
|
1672
Energizer
ENR
$1.44B
| $938K | ﹤0.01% |
31,863
+2
| +0% | +$60 |
|
|
HBI
1673
DELISTED
Hanesbrands
HBI
| $937K | ﹤0.01% |
161,675
+9
| +0% | +$43 |
|
1674
MillerKnoll
MLKN
$1.53B
| $933K | ﹤0.01% |
37,689
-2
| -0% | -$56 |
|
1675
LegalZoom.com
LZ
$1.35B
| $933K | ﹤0.01% |
70,017
+30,682
| +78% | +$353K |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.